Cancer News and Research

Latest Cancer News and Research

Cancer patients who get separated at the time of diagnosis face low survival rates

Among unmarried cancer patients, those who are separated at the time of diagnosis do not live as long as widowed, divorced, and never married patients. That is the conclusion of a new study to be published in the November 1, 2009 issue of Cancer, a peer-reviewed journal of the American Cancer Society.

24 Aug 2009

Simcere Pharmaceutical Group's forty-two generic drugs included in China's Essential Drug List

Simcere Pharmaceutical Group ("Simcere" or the "Company"), a leading manufacturer and supplier of branded generic and innovative pharmaceuticals in China, today announced that forty-two of its generic drugs have been included in China's Essential Drug List ("EDL"), which was issued by China's Ministry of Health ("MOH") on August 18, 2009.

24 Aug 2009

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

A cellular molecule that not only can sense two common respiratory viruses but also can direct cells to mount a defense has been identified by microbiologists at The University of Texas Health Science Center at San Antonio.

24 Aug 2009

Research study links partial epilepsy to the disruption of brain development during early childhood

A form of partial epilepsy associated with auditory and other sensory hallucinations has been linked to the disruption of brain development during early childhood, according to a study led by researchers at Beth Israel Deaconess Medical Center (BIDMC).

24 Aug 2009

New noninvasive technique to detect colorectal and gastric cancers found

A preliminary evaluation of methylation of two gene promoters in fecal DNA showed promise as a noninvasive method to detect colorectal and gastric cancers, according to a new study published online August 21 in the Journal of the National Cancer Institute.

24 Aug 2009

Scientific advancement in treating blood-related cancers leads to better survival rates

A recent analysis has found that adolescents and young adults who were recently diagnosed with blood-related cancers have better long-term survival rates than those who were diagnosed in the 1980s.

24 Aug 2009

New minimally invasive surgery techniques and instruments reduce tissue damage and infection

New, delicate surgery techniques to hunt for tumours could benefit from a lighter touch - but from a robot, rather than from a human hand. Canadian researchers have created a touchy-feely robot that detects tougher tumour tissue in half the time, and with 40% more accuracy than a human. The technique also minimises tissue damage.

24 Aug 2009

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Colorectal cancer (CRC) is the second leading cause of cancer-related death in the Western world. Fortunately physicians today have an abundance of drug therapies available to improve survival length for more advanced cancer patients. Now the discovery of genetic biomarkers relevant to CRC means that targeted personalised medication is increasingly common.

24 Aug 2009

Genway Clinical Laboratory offers ELISA-based test that detects tumor markers in blood serum

GenWay Clinical Laboratory, a US-based diagnostic company with CLIA certification, has validated a general tumor marker test in their laboratory and now offers this testing service. This is an ELISA-based assay which simply requires a small blood sample from the patient in order to quantify the amount of the tumor marker in their serum.

24 Aug 2009

CIGNA Health Awareness Tour team to help raise money and awareness for cancer prevention

Nearly 100 members of the CIGNA Health Awareness Tour team will walk, bike and run into Blue Bell Sunday to help raise money and awareness for cancer prevention.

24 Aug 2009

Discovery of mutation in AIP gene associated with acromegaly

An indigenous family living in a mountainous area of Malaysian Borneo helped Van Andel Research Institute (VARI) researchers to discover information about genetic mutations associated with acromegaly, a form of gigantism that often results in enlarged hands, feet, and facial features.

24 Aug 2009

Brits defend National Health Service against U.S. criticism

The United Kingdom's National Health System enters into the health care debate amid comparisons of the British and American health care systems. Meanwhile, British politicians defend NHS against critics.

23 Aug 2009

Nutra Pharma launches Cobroxin for chronic pain relief

Nutra Pharma Corp. (OTCBB: NPHC), a biotechnology company that is developing treatments for Adrenomyeloneuropathy (AMN), HIV and Multiple Sclerosis (MS), has announced today that it has launched an over-the-counter (OTC) pain reliever, Cobroxin, for the treatment of Stage 2 (moderate to severe) chronic pain.

21 Aug 2009

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

...

21 Aug 2009

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

CEL-SCI Corporation. (NYSE Amex: CVM), a biotechnology company entering a late stage oncology trial and focused on infectious disease, today announced that it has entered into a definitive agreement with several institutional investors to sell 9.7 million units, with each unit consisting of one of the Company's common shares and 0.50 warrants to purchase one share of common stock, for gross proceeds of approximately $4.4 million, before deducting placement agent fees and estimated offering expenses, in a "registered direct" offering.

21 Aug 2009

Cannabis chemicals stop prostate cancer growth

Active chemicals in cannabis have been shown to halt prostate cancer cell growth according to research published in the British Journal of Cancer today.

21 Aug 2009

Real Americans share experiences, common need for patient-centric reform

Teva Pharmaceuticals USA, the world's leading generic pharmaceutical company, today announced the start of its "Patient First" project as part of the Year of Affordable Healthcare campaign. The initiative, available at: www.yearofaffordablehealth.com/patients, features a first-hand perspective of everyday Americans as they struggle with the enormous and sometimes insurmountable expense of paying for their prescription medicines.

21 Aug 2009

University Of Phoenix and Odessa Chambliss Quality Of Life Fund collaborate to offer nursing scholarships

University of Phoenix today announced a partnership with Odessa Chambliss Quality of Life Fund to provide access to nursing education and help ensure the future of quality healthcare. Through this partnership, two full-tuition scholarships will be offered to nurses pursuing advanced degrees in the state of Florida.

21 Aug 2009

Phase Forward acquires Covance’s IVRS/IWRS business units

Phase Forward (NASDAQ: PFWD), a leading provider of data management solutions for clinical trials and drug safety, today announced that it has completed its previously announced acquisition of the Interactive Voice and Web Response Services (IVRS/IWRS) business of Covance Inc. (NYSE: CVD). Phase Forward purchased the Covance business unit for $10 million in cash. As part of the transaction, Phase Forward and Covance have entered into a multi-year marketing agreement to provide Phase Forward’s market-leading InForm™ electronic data capture (EDC) solution and Clarix™ Interactive Response Technology (IRT) application as the preferred EDC and IRT solutions to Covance clients.

21 Aug 2009

Ends of protein templates useful for arresting growth of cancerous cells

The tail ends of cellular protein templates, regions often thought relatively inconsequential, may actually play a role in preventing normal cells from becoming cancerous. The finding from scientists at Whitehead Institute for Biomedical research is reported in the August 20 edition of Cell.

21 Aug 2009

Cancer News and Research

Latest Cancer News and Research

Cancer patients who get separated at the time of diagnosis face low survival rates

Simcere Pharmaceutical Group's forty-two generic drugs included in China's Essential Drug List

Microbiologists discover new therapies for human respiratory syncytial virus and influenza A virus

Research study links partial epilepsy to the disruption of brain development during early childhood

New noninvasive technique to detect colorectal and gastric cancers found

Scientific advancement in treating blood-related cancers leads to better survival rates

New minimally invasive surgery techniques and instruments reduce tissue damage and infection

Discovery of genetic biomarkers enable targeted personalised medication for Colorectal cancer

Genway Clinical Laboratory offers ELISA-based test that detects tumor markers in blood serum

CIGNA Health Awareness Tour team to help raise money and awareness for cancer prevention

Discovery of mutation in AIP gene associated with acromegaly

Brits defend National Health Service against U.S. criticism

Nutra Pharma launches Cobroxin for chronic pain relief

Role of life sciences and health care industries in shaping national health care reforms emphasized at summit hosted by Cherokee Pharmaceuticals

CEL-SCI to raise $4.4 million by selling 9.7 million units to institutional investors

Cannabis chemicals stop prostate cancer growth

Real Americans share experiences, common need for patient-centric reform

University Of Phoenix and Odessa Chambliss Quality Of Life Fund collaborate to offer nursing scholarships

Phase Forward acquires Covance’s IVRS/IWRS business units

Ends of protein templates useful for arresting growth of cancerous cells

Cancer Research - Second Edition eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Cancer News and Research

Latest Cancer News and Research

Cancer Research - Second Edition eBook

Exploring the role of confocal-based high-content imaging in advancing core facilities

Transforming Cardiovascular Care: Insights from Mina Makar at AstraZeneca

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Newsletters you may be interested in